AZR Azora Therapeutics Inc

Price (delayed)

$3.89

Market cap

$10.21M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$15.46

Enterprise value

-$18.5M

?
Relative Growth: Rel. Growth: 6
Relative Strength: Rel. Strength: 80
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 0
Highlights
Azora Therapeutics's quick ratio has surged by 85% QoQ and by 15% YoY
The company's EPS has shrunk by 75% QoQ but it rose by 42% YoY

Key stats

What are the main financial stats of AZR

AZR stock price

How has the Azora Therapeutics stock price performed over time
Intraday
2.1%
1 week
5.71%
1 month
-5.58%
1 year
-55.49%
YTD
-29.27%
QTD
-2.99%

Financial performance

How have Azora Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$57.68M
Net income
-$57.8M
Gross margin
N/A
Net margin
N/A

Price vs fundamentals

How does AZR's price correlate with its fundamentals

Growth

What is Azora Therapeutics's growth rate over time

Valuation

What is Azora Therapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has shrunk by 75% QoQ but it rose by 42% YoY

Efficiency

How efficient is Azora Therapeutics business performance

Dividends

What is AZR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AZR.

Financial health

How did Azora Therapeutics financials performed over time
Azora Therapeutics's quick ratio has surged by 85% QoQ and by 15% YoY
AZR's current ratio has surged by 77% since the previous quarter and by 12% year-on-year
Azora Therapeutics's debt is 100% more than its equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.